頁籤選單縮合
題 名 | 實證藥學改善短效型Nifedipine應用=Evidence-Based Pharmacy Improving Short-Acting Nifedipine |
---|---|
作 者 | 蕭如君; 張峻瑋; 賴永融; 蔡敏鈴; | 書刊名 | 藥學雜誌 |
卷 期 | 28:3=112 2012.09[民101.09] |
頁 次 | 頁123-128 |
分類號 | 418.221 |
關鍵詞 | 高血壓危象; 實證藥學; Hypertensive crisis; Evidence-based pharmacy; |
語 文 | 中文(Chinese) |
中文摘要 | 許多臨床研究結論皆強調使用短效型 nifedipine 來快速的降低血壓易造成腦部、腎臟及心肌缺血之副作用,所以基於安全性的考量,早在1985 年美國食品及藥物管理局 (Food and Drug Administration, FDA) 便已建議以短效型 nifedipine 來治療高血壓急症是既不安全又無療效的方法,但目前在本院門診仍有不少慢性高血壓患者在使用短效型 nifedipine 以長期控制不穩定的血壓,因此藥劑科於99/10/01-100/03/31依據實證來進行改善方案。在實證的介入後獲得很顯著的成效,由平均每月用量3,120顆,下降為平均每月用量2,400顆,平均每月下降720顆 (P值<0.05)。確實地實行藥師應用實證證據於臨床治療改善、本著實證藥學的精神、根據目前的最佳證據、配合臨床專家的意見及考量病人的期望,做出最適合於病人的建議,將實證藥學應用於臨床。 |
英文摘要 | Several studies demonstrated that nifedipine, a short-acting antihypertensive medication, may cause adverse effects on the brain and the kidney, and may even induce myocardial ischemia. Since 1985, the Food and Drug Administration (FDA) suggested that nifedipine was not safe and not effective in the treatment of hypertension. However, some doctors still prescribe short-acting nifedipine for control of unstable blood pressure. Our pharmacy department carried out a drug safety campaign supported by evidence-based pharmacy. The doctors that prescribed nifedipine frequently for control of hypertension were interviewed from Oct. 1st, 2010 to Mar. 31st, 2011. After this campaign, nifedipine use in our institution dropped an average of 720 pills every month (P value <0.05). Promotion of new knowledge from evidenced-based pharmacy enhances its clinical application and improves quality of patient care. |
本系統中英文摘要資訊取自各篇刊載內容。